Alkermes
ALKSAlkermes plc is a biopharmaceutical company that focuses on central nervous system (CNS) diseases such as such as schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), t …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Alkermes
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/3/2026 | Sell | Gaffin, David Joseph | EVP, CLO, Alkermes, Inc. | $29.8 | $60,532 |
| 3/2/2026 | Sell | Gaffin, David Joseph | EVP, CLO, Alkermes, Inc. | $29.3 | $59,576 |
| 3/2/2026 | Sell | Hopkinson, Craig C. | EVP R&D, Chief Medical Officer | $29.7 | $267,485 |
| 3/2/2026 | Sell | Nichols, Christian Todd | SVP, Chief Commercial Officer | $30.0 | $180,000 |
| 3/2/2026 | Sell | Parisi, Samuel Joseph | VP, Finance (Interim PAO) | $29.3 | $201,808 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)